A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

Angela M. Minassian, Rosalind Rowland, Natalie E.R. Beveridge, Ian D. Poulton, Iman Satti, Stephanie Harris, Hazel Poyntz, Matthew Hamill, Kristin Griffiths, Clare R. Sander, David R. Ambrozak, David A. Price, Brenna J. Hill, Joseph P. Casazza, Daniel C. Douek, Richard A. Koup, Mario Roederer, Alan Winston, Jonathan Ross, Jackie SherrardGuy Rooney, Nicola Williams, Alison M. Lawrie, Helen A. Fletcher, Ansar A. Pathan, Helen McShane*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    41 Citations (Scopus)
    Original languageEnglish
    Article numbere000223
    JournalBMJ Open
    Volume1
    Issue number2
    DOIs
    Publication statusPublished (VoR) - 2011

    Fingerprint

    Dive into the research topics of 'A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults'. Together they form a unique fingerprint.

    Cite this